Vincerx Pharma Inc (VINC)
0.325
-0.01
(-4.24%)
USD |
NASDAQ |
Nov 13, 16:00
0.3187
-0.01
(-1.94%)
After-Hours: 20:00
Vincerx Pharma Market Cap: 9.643M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 9.643M |
| November 12, 2024 | 10.07M |
| November 11, 2024 | 10.44M |
| November 08, 2024 | 9.712M |
| November 07, 2024 | 9.560M |
| November 06, 2024 | 9.703M |
| November 05, 2024 | 10.27M |
| November 04, 2024 | 10.62M |
| November 01, 2024 | 10.83M |
| October 31, 2024 | 10.36M |
| October 30, 2024 | 10.39M |
| October 29, 2024 | 10.98M |
| October 28, 2024 | 11.05M |
| October 25, 2024 | 11.28M |
| October 24, 2024 | 11.48M |
| October 23, 2024 | 10.80M |
| October 22, 2024 | 11.46M |
| October 21, 2024 | 11.22M |
| October 18, 2024 | 11.28M |
| October 17, 2024 | 11.20M |
| October 16, 2024 | 11.81M |
| October 15, 2024 | 11.27M |
| October 14, 2024 | 12.02M |
| October 11, 2024 | 11.63M |
| October 10, 2024 | 11.49M |
| Date | Value |
|---|---|
| October 09, 2024 | 11.87M |
| October 08, 2024 | 12.09M |
| October 07, 2024 | 20.71M |
| October 04, 2024 | 21.66M |
| October 03, 2024 | 21.22M |
| October 02, 2024 | 20.57M |
| October 01, 2024 | 20.33M |
| September 30, 2024 | 21.25M |
| September 27, 2024 | 20.33M |
| September 26, 2024 | 20.77M |
| September 25, 2024 | 20.48M |
| September 24, 2024 | 22.46M |
| September 23, 2024 | 21.37M |
| September 20, 2024 | 21.67M |
| September 19, 2024 | 20.75M |
| September 18, 2024 | 20.41M |
| September 17, 2024 | 20.84M |
| September 16, 2024 | 20.77M |
| September 13, 2024 | 20.90M |
| September 12, 2024 | 21.05M |
| September 11, 2024 | 20.49M |
| September 10, 2024 | 21.07M |
| September 09, 2024 | 21.90M |
| September 06, 2024 | 21.19M |
| September 05, 2024 | 22.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.560M
Minimum
Nov 07 2024
362.20M
Maximum
Mar 16 2021
97.87M
Average
30.67M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 38.75M |
| AIM ImmunoTech Inc | 15.32M |
| IGC Pharma Inc | 27.77M |
| NovaBay Pharmaceuticals Inc | 3.481M |
| Protalix BioTherapeutics Inc | 91.19M |
Market Cap Related Metrics
| Price to Book Value | 0.6242 |
| Price | 0.325 |
| Earnings Yield | -406.2% |